Clinical Trials Directory

Trials / Unknown

UnknownNCT01414530

Oral Contraceptive During Menopausal Transition

Effects of Oral Contraceptive on Muscle or Joint Ache in Women During Menopausal Transition

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
52 (estimated)
Sponsor
Samsung Medical Center · Academic / Other
Sex
Female
Age
45 Years – 60 Years
Healthy volunteers
Accepted

Summary

Muscle or joint pain is one of the most common symptoms during menopausal transition. As this could be severe enough to affect social and daily life and to reduce quality of life, attentions should be paid about this. Although understanding of muscle or joint pain related to menopause is still insufficient, estrogen can play an important role. Previous studies have shown that estrogen protects cartilage in both animals and humans. However, perimenopause is different from postmenopause, in the point that estrogen is still secreted with a great fluctuation. Until now, no study has been performed to evaluate the effects of oral contraceptive on muscle or joint pain in women during menopausal transition. Moreover, since menopausal symptoms vary according to ethnicity and culture, a study in Korean population is necessary. Therefore, this randomized controlled trial was designed to evaluate the effects of oral contraceptive on muscle or joint pain in women during menopausal transition, compared to NSAID (non-steroidal anti-inflammatory drug).

Conditions

Interventions

TypeNameDescription
DRUGoral contraceptiveethinyl estradiol 0.03mg/levonorgestrel 0.15mg daily for 8 weeks
DRUGNSAIDibuprofen 200mg/arginine 185mg twice per day for 8 weeks

Timeline

Start date
2010-04-01
Primary completion
2014-06-01
First posted
2011-08-11
Last updated
2013-09-10

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT01414530. Inclusion in this directory is not an endorsement.

Oral Contraceptive During Menopausal Transition (NCT01414530) · Clinical Trials Directory